Arthrex Net Worth: Is This Medical Giant Overvalued Or Underrated?

Arthrex has raised $1. 67m over 1 rounds. Arthrex's latest funding round was a unattributed vc for $1. 67m on. Valuations are submitted by companies,. Reinhold schmieding is the founder and ceo of arthrex, a medical device company specializing in orthopedic products. Arthrex has an estimated revenue of $2. 2b, and 8. 6k employees.

Schmieding owns more than 90% of the company. Schmieding is the son of german immigrants who moved to the u. s. Arthrex's annual revenues are over $500 million (see exact revenue data) what industry is the company in? Arthrex is classified as operating in the surgical & medical. Arthrex manufactures and distributes orthopedic surgery products to the healthcare sector. Arthrexs primary competitors include zimmer biomet, smith & nephew, nuvasive and 11 more. In 2011, arthrex, a company led by one of collier countys richest men, asked for $2 million in government incentives to expand in the county. The request by the company,. Manufactures and markets arthroscopic surgery products. Its products are used for incisions made in joints to relieve injuries from arthritis, tendonitis, torn cartilage, and bone. The company offers a variety of products for arthroscopic and minimally invasive orthopaedic surgical procedures as well as provides medical education services, enabling healthcare.

The company offers a variety of products for arthroscopic and minimally invasive orthopaedic surgical procedures as well as provides medical education services, enabling healthcare.